Clinical Trial Update: Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment [Phase 3]

View source ↗

Summary

Phase 3 study evaluating treatment for anti-r-HuEpo–associated pure red cell aplasia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pure Red Cell Aplasia

Snippet

Sponsor: Chulalongkorn University | Conditions: Anti-r-HuEpo Associated PRCA Subjects | Phase 3 | Status: TERMINATED